Safety margin of minimized contrast volume during percutaneous coronary intervention in patients with chronic kidney disease

Cardiovascular Intervention and Therapeutics

Volumn 29, Issue 3, 2014, Pages 209-215

  Ogata, Nobuhiko ^a   Ikari, Yuji ^a   Nanasato, Mamoru ^b   Okutsu, Masaaki ^c   Kametani, Ryosuke ^d   Abe, Mitsuru ^e   Uehara, Yoshiki ^f   Sumitsuji, Satoru ^g  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^c Tokushukai Nozaki Hospital   (Japan)

^d Nagoya Tokushukai General Hospital   (Japan)

^e NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^f JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

CKD; Contrast induced acute kidney injury; IVUS; PCI; Renalism

Indexed keywords

CONTRAST MEDIUM; CREATININE; IOHEXOL; IOMEPROL; IOPAMIDOL;

AGED; ARTICLE; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG MEGADOSE; EVENT FREE SURVIVAL; FEMALE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; INTRAVENOUS UROGRAPHY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; CHEMICALLY INDUCED; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPLICATION; CORONARY DISEASE; ENDOSCOPIC ECHOGRAPHY; MULTICENTER STUDY; PROCEDURES; RETROSPECTIVE STUDY;

ACUTE KIDNEY INJURY; AGED; CONTRAST MEDIA; CORONARY DISEASE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; PERCUTANEOUS CORONARY INTERVENTION; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84904434065     PISSN: 18684300     EISSN: 18684297     Source Type: Journal    
DOI: 10.1007/s12928-014-0245-9     Document Type: Article

References (23)

1. Abe M, Kimura T, Morimoto T, Furukawa Y, Kita T. Incidence of and risk factors for contrast-induced nephropathy after cardiac catheterization in Japanese patients. Circ J. 2009;73(8): 1518-22.
2. Gruberg L, Mintz GS, Mehran R, Gangas G, Lansky AJ, Kent KM, Pichard AD, Satler LF, Leon MB. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol. 2000;36(5): 1542-8.
3. Goldenberg I, Chonchol M, Guetta V. Reversible acute kidney injury following contrast exposure and the risk of long-term mortality. Am J Nephrol. 2009;29(2): 136-44.
4. Mager A, Vaknin Assa H, Lev EI, Bental T, Assali A, Kornowski R. The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction. Catheter Cardiovasc Interv. 2011;78(2): 198-201.
5. Kawamura Y, Morino Y, Nagaoka M, Matsukage T, Masuda N, Ikari Y. Impact of chronic kidney disease on clinical and angiographic results following implantation of sirolimus-eluting coronary stents. Cardiovasc Interv Ther. 2011;26(1): 18-25.
6. Morikawa S, Sone T, Tsuboi H, Mukawa H, Morishima I, Uesugi M, Morita Y, Numaguchi Y, Okumura K, Murohara T. Renal protective effects and the prevention of contrast-induced nephropathy by atrial natriuretic peptide. J Am Coll Cardiol. 2009;53(12): 1040-6.
7. Chen HH. Atrial natriuretic peptide for the prevention of contrast-induced nephropathy: what's old is new but at the right dose and duration of therapy! J Am Coll Cardiol. 2009;53(12): 1047-9.
8. Kawashima S, Takano H, Iino Y, Takayama M, Takano T. Prophylactic hemodialysis does not prevent contrast-induced nephropathy after cardiac catheterization in patients with chronic renal insufficiency. Circ J. 2006;70(5): 553-8.
9. Quintavalle C, Fiore D, De Micco F, Visconti G, Focaccio A, Golia B, Ricciardelli B, Donnarumma E, Bianco A, Zabatta MA, Troncone G, Colombo A, Briguori C, Condorelli G. Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury. Circulation. 2012;126(25): 3008-16.
10. Chertow GM, Normand SL, McNeil BJ. "Renalism": inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. J Am Soc Nephrol. 2004;15(9): 2462-8.
11. Cigarroa RG, Lange RA, Williams RH, Hillis LD. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med. 1989;86(6 Pt 1): 649-52.
12. Laskey WK, Jenkins C, Selzer F, Marroquin OC, Wilensky RL, Glaser R, Cohen HA, Holmes DR Jr. Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. J Am Coll Cardiol. 2007;50(7): 584-90.
13. Barrett BJ, Parfrey PS. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med. 2006;354(4): 379-86.
14. Kane GC, Doyle BJ, Lerman A, Barsness GW, Best PJ, Rihal CS. Ultra-low contrast volumes reduce rates of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography. J Am Coll Cardiol. 2008;51(1): 89-90.
15. Ogata N, Matsukage T, Toda E, Tamiya S, Fujii T, Nakazawa G, Masuda N, Morino Y, Ikari Y. Intravascular ultrasound-guided percutaneous coronary interventions with minimum contrast volume for prevention of the radiocontrast-induced nephropathy: report of two cases. Cardiovasc Interv Ther. 2011;26(1): 83-8.
16. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6): 982-92.
17. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44(7): 1393-9.
18. Freeman RV, O'Donnell M, Share D, Meengs WL, Kline-Rogers E, Clark VL, DeFranco AC, Eagle KA, McGinnity JG, Patel K, Maxwell-Eward A, Bondie D, Moscucci M. Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol. 2002;90(10): 1068-73.
19. McCullough PA, Adam A, Becker CR, Davidson C, Lameire N, Stacul F, Tumlin J. Risk prediction of contrast-induced nephropathy. Am J Cardiol. 2006;98(6A): 27K-36K.
20. Altmann DB, Zwas D, Spatz A, Bergman G, Spokojny A, Rivai S, Sanborn TA. Use of the contrast volume to estimated creatinine clearance ratio to predict renal failure after angiography. J Interv Cardiol. 1997;10(2): 113-9.
21. Nyman U, Bjork J, Aspelin P, Marenzi G. Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention. Acta Radiol. 2008;49(6): 658-67.
22. Brown JR, Robb JF, Block CA, Schoolwerth AC, Kaplan AV, O'Connor GT, Solomon RJ, Malenka DJ. Does safe dosing of iodinated contrast prevent contrast-induced acute kidney injury? Circ Cardiovasc Interv. 2010;3(4): 346-50.
23. Tanaga K, Tarao K, Nakamura Y, Inoue T, Jo K, Ishikawa T, Miyazaki A. Percutaneous coronary intervention causes increase of serum cystatin C concentration even in the patients with a low risk of contrast-induced nephropathy. Cardiovasc Interv Ther. 2012;27: 168-73.